TargetRx's Mike Luby Honored as Influential Industry Leader in PharmaVOICE 100

Pharmaceutical Sales and Marketing Expert Recognized as Driving Force in Life Sciences Industry

Horsham, PA - July 31, 2006 - TargetRx, a pharmaceutical sales and marketing effectiveness company, today announced that Mike Luby has been selected by PharmaVOICE as one of the "100 Most Inspiring People in the Life Sciences Industry." PharmaVOICE, a valued resource that delivers the views and insights of executives who are shaping the dynamic life sciences industry, will unveil its second annual PharmaVOICE 100 issue in August.

Luby was selected as one of the PharmaVOICE 100 from a group of nominations submitted by readers. A panel of PharmaVOICE editors evaluated the submissions based on the individual's ability to inspire, motivate and influence corporate leadership, research and development, technology, creativity, marketing, and strategy.

"In his six years at TargetRx, Mike has provided the industry with new intelligence, identifying opportunities for increased efficiency and effectiveness in sales and marketing practices," said Dr. William Trombetta, chair of the pharmaceutical marketing program at Saint Joseph's University in Philadelphia. "This honor represents Mike's ability to motivate and inspire others from colleagues to clients through his clear grasp of the issues facing pharmaceutical companies today and his position at the forefront of industry innovation."

Luby has been recognized by PharmaVOICE for his vision to provide a solution to one of the pharmaceutical industry's most pressing problems, improving the effectiveness of sales and marketing. An industry thought-leader and bold entrepreneur, Luby has led the team at TargetRx to develop the industry's most powerful database of physician attitudinal information that continually tracks physician attitudes and behaviors. This database, coupled with TargetRx's patented method of analysis, enables the Company to accurately predict brand performance and identify tangible opportunities for pharmaceutical companies to improve their execution in both the sales and marketing functions.

"The second annual issue of the PharmaVOICE 100 is dedicated to the unique individuals who have been recognized by the readers of the publication for their positive contributions through leadership, mentoring, and inspiration," said Taren Grom, PharmaVOICE editor. "Through their actions and passion for the industry, these individuals serve as examples of how one person can make a difference to many. These 100 men and women are being recognized for their contributions to the life sciences industry and for the positive impact they are having on moving the industry forward. We are honored to showcase these individuals who are making a difference."

As founder and CEO of TargetRx, Luby brings more than 15 years of pharmaceutical marketing and sales experience from a variety of therapeutic areas. Under Luby's leadership since being founded in 1999, TargetRx has succeeded in raising more than $50 million in capital, expanding its team to more than 100 employees, and securing clients in the majority of the top 30 pharmaceutical companies worldwide. Luby is also the lead author on TargetRx's patented method of analyzing the effectiveness of marketing and sales strategies. Prior to forming TargetRx, Luby spent 10 years at Merck & Co., Inc., where he created and executed marketing strategies for both the specialty and mass markets. The concept for TargetRx was born from his dissatisfaction with the lack of insightful, predictive and actionable marketing information from external sources during his tenure at Merck. Luby holds a B.A. in economics from Dartmouth College and an M.B.A. from the Wharton School of the University of Pennsylvania.


About PharmaVOICE
Published 12 times a year, PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE reaches more than 17,000 readers every month.

About TargetRx

TargetRx provides pharmaceutical and biotech companies with unique insight into the true drivers of product choice and adoption for their brands, helping clients to confidently take the actions that will grow their businesses and help patients. Serving the majority of the top 30 pharmaceutical and biotech companies, TargetRx enables clients to significantly improve the launch of new products and indications, physician segmentation and targeting, creation of professional messaging and materials, and sales and marketing execution and effectiveness. All TargetRx solutions are powered by our AdvantageBuilderSM normative database and validated predictive models, created from capturing in-depth physician attitudes on the "four forces" of prescribing - product, payor, promotion and patient - on new launches, marketing campaigns and physician-rep interactions on over 500 pipeline and inline brands and modeling these attitudes against actual prescribing behavior. For more information, visit www.targetrx.com.

Media Contact:

Joe Ford
Phone: 215-444-8722
jford@targetrx.com